By Dr Mark C Field, Department of Biological Sciences at Imperial College, London, and Dr Mark Carrington, Department of Biochemistry at the University of Cambridge, UK
Dr Mark C Field is at the Department of Biological Sciences, Imperial College. He was educated at Oxford Univeristy and completed his doctoral work there at the Glycobiology Institute on glyoprotein structure and function. His postdoctoral career began in the US where he started to work on trypanosomatids at the Rockefeller and Stanford Universities, as well as a short period at Genentech Inc. In 1994, he established his own research group at Imperial College, London, which focuses on the molecular cell biology of Trypanosoma brucei.
Dr Mark Carrington is at the Department of Biochemistry, University of Cambridge. He was educated at Cambridge, obtaining his PhD in Plant Molecular Biology. He has worked on trypanosomes since the start of his postdoctoral career and has extensive experience in the study of protein structure and RNA processing, and is interested in the development of therapeutics based on surface proteins and on host-resistance mechanisms.
|
|
